Results 211 to 220 of about 49,721 (234)

Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis

Critical Reviews in Oncology/Hematology, 2019
Yuhong Zhou, Hong Sun, Weimin Cai
exaly  

Nab-paclitaxel

Reactions Weekly
openaire   +1 more source

Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69)

Breast Cancer Research and Treatment, 2017
Sibylle Loibl, Christian Jackisch, Sherko Kuemmel   +2 more
exaly  

Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)

Annals of Oncology, 2009
B R Laplant, V Roy
exaly  

Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration

Cancer Chemotherapy and Pharmacology, 2015
Maria Palmisano, Simon Zhou
exaly  

Metabolism of the taxanes including nab-paclitaxel

Expert Opinion on Drug Metabolism and Toxicology, 2015
Markus Joerger
exaly  

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma

Annals of Oncology, 2015
Michele del Vecchio, Axel Hauschild, Shailender Bhatia   +2 more
exaly  

Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma

European Journal of Cancer, 2020
Keith Flaherty, Kenneth Yu, Eileen M O'Reilly   +2 more
exaly  

Nab-paclitaxel in the treatment of metastatic breast cancer: a comprehensive review

Expert Review of Clinical Pharmacology, 2011
C Marcela Díaz-Montero, Stefan Glück
exaly  

Pharmacokinetics and pharmacodynamics of nab ‐paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent‐based paclitaxel

Journal of Clinical Pharmacology, 2014
Rajesh Chopra
exaly